Concepedia

Nicholas J. DePolo

NJ

Statistics

Publications

8

Citations

513

H-Index

8

Active since

1986

Affiliations

CE Technologies (United Kingdom)(Current)

University of California San Diego

Nicholas J. DePolo is an author at CE Technologies (United Kingdom) specializing in virology, medicine, and pathogenesis.

Top concepts

Publications per year

1986–2000

8

Publications

8

VSV-G Pseudotyped Lentiviral Vector Particles Produced in Human Cells Are Inactivated by Human Serum

Nicholas J. DePolo, Joyce D. Reed, Philip L. Sheridan et al. · Molecular Therapy · 2000 · 208 citations · Full text

Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles

Nicholas J. DePolo, Cristina Giachetti, John J. Holland · Journal of Virology · 1987 · 90 citations · Full text

, , +14

Generation of Retroviral Packaging and Producer Cell Lines for Large-Scale Vector Production and Clinical Application: Improved Safety and High Titer

Philip L. Sheridan, Mordechai Bodner, Andrea Lynn et al. · Molecular Therapy · 2000 · 68 citations · Full text

The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent

Nicholas J. DePolo, Cataline E. Harkleroad, Mordechai Bodner et al. · Journal of Virology · 1999 · 48 citations · Full text

, , +19

Evaluation of PCR and ELISA Assays for Screening Clinical Trial Subjects for Replication-Competent Retrovirus

Darlene Martineau, WOLFGANG M. KLUMP, James E. McCormack et al. · Human Gene Therapy · 1997 · 33 citations

Rows per page

1–5 of 8